Eric Topol highlights major RAS pancreatic cancer advance, MYC next in line
EricTopol · x · 2026-10-05
Eric Topol points to a recent, momentous therapeutic advance against RAS in pancreatic cancer, framing it as progress in the march against "undruggable" cancer genes — and asks whether MYC could be next. Shared via a gift link to a longer report.
More from AGI Musings
- Economist praises fully disclosed AI-generated research as the right way forward — paulnovosad · 2026-10-05
- Perspective warns AI can breed illusions of understanding and scientific monocultures — MichaelRetchin · 2026-10-05
- Are AI companies faking the apocalypse? How regulation could entrench Big AI — frugal-tech-worker · 2026-10-05
- Kai-Fu Lee: After 100+ CEO interviews, the biggest AI transformation mistake is treating AI as another tech cycle — kaifulee · 2026-10-05
- Blogger calls out Anthropic's contradiction: tool or $2T-enslaved sentient being? — alexeyguzey · 2026-10-05
- DearCai CEO on 60 Minutes: AI labor shift will be the most consequential of our lifetimes — clarashih · 2026-10-05